In this study, RRMS patients in remission also had a reduced naïve (CD3−CD19+CD27−)/memory (CD3−CD19+CD27+) IL-10+ Bregs ratio in PBMCs (92). The gene discussed is IL10; the disease is relapsing-remitting multiple sclerosis.